What changed in this filing

/stocks — the workspaceLOADING

Item 1. Financial Statements

2023-05-09 compared with 2023-02-08 · 216 added, 115 removed, 885 unchanged (27% of the section changed)

3 unchanged sentences

CONSOLIDATED BALANCE SHEETS

December 31, 2022 and September 30, 2022

March 31, 2023 and September 30, 2022

(Dollars in thousands, except per share amounts)

37 unchanged sentences

CONSOLIDATED BALANCE SHEETS (continued)

December 31, 2022 and September 30, 2022

March 31, 2023 and September 30, 2022

(Dollars in thousands, except per share amounts)

7 unchanged sentences

50,000,000 shares authorized;

8,231,197 shares issued and outstanding - December 31, 2022 8,221,952 shares issued and outstanding - September 30, 2022

8,203,174 shares issued and outstanding - March 31, 2023 8,221,952 shares issued and outstanding - September 30, 2022

37,979 38,751

Retained earnings 190,177 180,535

Accumulated other comprehensive income (loss) ( 735 ) ( 717 )

Accumulated other comprehensive loss ( 495 ) ( 717 )

Total shareholders’ equity 227,661 218,569

5 unchanged sentences

CONSOLIDATED STATEMENTS OF INCOME

For the three months ended December 31, 2022 and 2021

For the three and six months ended March 31, 2023 and 2022

(Dollars in thousands, except per share amounts)

Three Months Ended December 31,

Three Months Ended March 31, Six Months Ended

2023 2022 2023 2022

Interest and dividend income

25 unchanged sentences

CONSOLIDATED STATEMENTS OF INCOME (continued)

For the three months ended December 31, 2022 and 2021

For the three and six months ended March 31, 2023 and 2022

(Dollars in thousands, except per share amounts)

Three Months Ended December 31,

Three Months Ended March 31, Six Months Ended

2023 2022 2023 2022

Non-interest expense

28 unchanged sentences

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

For the three months ended December 31, 2022 and 2021

For the three and six months ended March 31, 2023 and 2022

(Dollars in thousands)

Three Months Ended

March 31, Six Months Ended

2023 2022 2023 2022

Comprehensive income

Net income $ 6,663 $ 5,327 $ 14,169 $ 10,812

Other comprehensive loss

Unrealized holding loss on investment securities available for sale, net of income tax benefits of $( 5 ) and $( 5 ), respectively

Other comprehensive income (loss)

Unrealized holding gain (loss) on investment securities available for sale, net of income taxes of $ 64 , $( 40 ), $ 58 and $( 45 ), respectively

239 ( 152 ) 220 ( 170 )

1 unchanged sentence

Accretion of OTTI on investment securities held to maturity, net of income taxes of $ 0 , $ 1 , $ 1 and $ 1 , respectively

Total other comprehensive loss, net of income taxes ( 18 ) ( 17 )

Total other comprehensive income (loss), net of income taxes 240 ( 149 ) 222 ( 166 )

Total comprehensive income $ 6,903 $ 5,178 $ 14,391 $ 10,646

3 unchanged sentences

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

For the three months ended December 31, 2022 and 2021

For the three and six months ended March 31, 2023 and 2022

(Dollars in thousands, except per share amounts)

Number of Shares Amount Accumulated

Compre-hensive

Income (Loss)

Stock Retained

Earnings Total

Balance, December 31, 2021 8,348,821 $ 42,436 $ 167,897 $ 42 210,375

Net income — — 5,327 — 5,327

Other comprehensive loss — — — ( 149 ) ( 149 )

Repurchase of common stock ( 61,565 ) ( 1,716 ) — — ( 1,716 )

Exercise of stock options 18,570 202 — — 202

Common stock dividends ($ 0.22 per common share)

— — ( 1,836 ) — ( 1,836 )

Stock option compensation expense — 66 — — 66

Balance, March 31, 2022 8,305,826 $ 40,988 $ 171,388 $ ( 107 ) $ 212,269

Balance, December 31, 2022 8,231,197 $ 38,878 $ 185,406 $ ( 735 ) $ 223,549

Net income — — 6,663 — 6,663

Other comprehensive income — — — 240 240

Repurchase of common stock ( 34,263 ) ( 1,098 ) — — ( 1,098 )

Exercise of stock options 6,240 121 — — 121

Common stock dividends ($ 0.23 per common share)

— — ( 1,892 ) — ( 1,892 )

Stock option compensation expense — 78 — — 78

Balance, March 31, 2023 8,203,174 $ 37,979 $ 190,177 $ ( 495 ) $ 227,661

Common Stock Accumulated

11 unchanged sentences

Stock option compensation expense — 132 — — 132

Balance, December 31, 2021 8,348,821 $ 42,436 $ 167,897 $ 42 $ 210,375

Balance, March 31, 2022 8,305,826 $ 40,988 $ 171,388 $ ( 107 ) $ 212,269

Balance, September 30, 2022 8,221,952 $ 38,751 $ 180,535 $ ( 717 ) $ 218,569

Net income — — 14,169 — 14,169

Other comprehensive loss — — — ( 18 ) ( 18 )

Other comprehensive income — — — 222 222

Repurchase of common stock ( 44,833 ) ( 1,445 ) — — ( 1,445 )

3 unchanged sentences

Stock option compensation expense — 156 — — 156

Balance, December 31, 2022 8,231,197 $ 38,878 $ 185,406 $ ( 735 ) $ 223,549

Balance, March 31, 2023 8,203,174 $ 37,979 $ 190,177 $ ( 495 ) $ 227,661

See notes to unaudited consolidated financial statements

2 unchanged sentences

CONSOLIDATED STATEMENTS OF CASH FLOWS

For the three months ended December 31, 2022 and 2021

For the six months ended March 31, 2023 and 2022

(Dollars in thousands)

Three Months Ended December 31,

Six Months Ended March 31,

Cash flows from operating activities

25 unchanged sentences

Proceeds from maturities and prepayments of investment securities available for sale 3,921 12,152

Purchase of FHLB stock ( 8 ) ( 91 )

Increase in loans receivable, net ( 79,162 ) ( 64,193 )

5 unchanged sentences

CONSOLIDATED STATEMENTS OF CASH FLOWS (continued)

For the three months ended December 31, 2022 and 2021

For the six months ended March 31, 2023 and 2022

(Dollars in thousands)

Three Months Ended December 31,

Six Months Ended March 31,

Cash flows from financing activities

Net increase (decrease) in deposits $ ( 83,409 ) $ 85,871

Repayments of FHLB borrowings — ( 5,000 )

Proceeds from exercise of stock options 517 332

7 unchanged sentences

Supplemental disclosure of cash flow information

Income taxes paid $ 4,634 $ 2,188

Interest paid $ 3,214 $ 1,305

Supplemental disclosure of non-cash investing activities

Other comprehensive loss related to investment securities $ ( 18 ) $ ( 17 )

Other comprehensive income (loss) related to investment securities $ 222 $ ( 166 )

See notes to unaudited consolidated financial statements

9 unchanged sentences

The unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended September 30, 2022 (“2022 Form 10-K”).

The unaudited consolidated results of operations for the three months ended December 31, 2022 are not necessarily indicative of the results that may be expected for the entire fiscal year ending September 30, 2023.

The unaudited consolidated results of operations for the six months ended March 31, 2023 are not necessarily indicative of the results that may be expected for the entire fiscal year ending September 30, 2023.

(b) Principles of Consolidation:

5 unchanged sentences

Actual results could differ from those estimates.

(e) Certain prior period amounts have been reclassified to conform to the December 31, 2022 presentation with no change to previously reported net income or total shareholders’ equity.

(e) Certain prior period amounts have been reclassified to conform to the March 31, 2023 presentation with no change to previously reported net income or total shareholders’ equity.

(2) INVESTMENT SECURITIES

Held to maturity and available for sale investment securities have been classified according to management’s intent and were as follows as of December 31, 2022 and September 30, 2022 (dollars in thousands):

Held to maturity and available for sale investment securities have been classified according to management’s intent and were as follows as of March 31, 2023 and September 30, 2022 (dollars in thousands):

Losses Estimated

December 31, 2022

March 31, 2023

Held to maturity

22 unchanged sentences

Total $ 42,309 $ — $ ( 894 ) $ 41,415

Held to maturity and available for sale investment securities with unrealized losses were as follows as of December 31, 2022 (dollars in thousands):

Held to maturity and available for sale investment securities with unrealized losses were as follows as of March 31, 2023 (dollars in thousands):

Less Than 12 Months 12 Months or Longer Total

34 unchanged sentences

The Company has the ability and the intent to hold the investments until the fair value recovers.

Further, as of December 31, 2022, management does not have the intent to sell any of the securities classified as available for sale for which the estimated fair value is below the recorded value and believes that it is more likely than not that the Company will not have to sell such securities before a recovery of cost (or recorded value if previously written down).

Further, as of March 31, 2023, management does not have the intent to sell any of the securities classified as available for sale for which the estimated fair value is below the recorded value and believes that it is more likely than not that the Company will not have to sell such securities before a recovery of cost (or recorded value if previously written down).

The Company bifurcates OTTI into (1) amounts related to credit losses which are recognized through earnings and (2) amounts related to all other factors which are recognized as a component of other comprehensive income (loss).

2 unchanged sentences

Significant judgment by management is required in this analysis that includes, but is not limited to, assumptions regarding the collectability of principal and interest, net of related expenses, on the underlying loans.

The following table presents a summary of the significant inputs utilized to measure management’s estimates of the credit loss component on OTTI securities as of December 31, 2022 and 2021:

The following table presents a summary of the significant inputs utilized to measure management’s estimates of the credit loss component on OTTI securities as of March 31, 2023 and 2022:

Range Weighted

Minimum Maximum Average

December 31, 2022

March 31, 2023

Constant prepayment rate 6.00 % 15.00 % 7.38 %

1 unchanged sentence

Loss severity rate — % 3.17 % 1.04 %

December 31, 2021

March 31, 2022

Constant prepayment rate 6.00 % 15.00 % 8.37 %

1 unchanged sentence

Loss severity rate — % 8.53 % 3.72 %

The following table presents a roll forward of the credit loss component of held to maturity and available for sale debt securities that have been written down for OTTI with the credit loss component recognized in earnings for the three months ended December 31, 2022 and 2021 (dollars in thousands):

Three Months Ended

The following table presents a roll forward of the credit loss component of held to maturity and available for sale debt securities that have been written down for OTTI with the credit loss component recognized in earnings for the six months ended March 31, 2023 and 2022 (dollars in thousands):

Six Months Ended

Beginning balance of credit loss $ 836 $ 853

Additions (subtractions):

Net realized gain (losses) previously recorded

Net realized gain (loss) previously recorded

as credit losses

1 unchanged sentence

Ending balance of credit loss $ 822 $ 846

During the three months ended December 31, 2022, the Company recorded a $ 7,000 net realized loss on 14 held to maturity investment securities.

During the three months ended December 31, 2021, the Company recorded a $ 3,000 net realized loss (as a result of investment securities being deemed worthless) on 15 held to maturity investment securities, all of which had been recognized previously as a credit loss.

The recorded amount of investment securities pledged as collateral for public fund deposits, federal treasury tax and loan deposits, FHLB collateral and other non-profit organization deposits totaled $ 160.19 million and $ 133.82 million at December 31, 2022 and September 30, 2022, respectively.

The contractual maturities of debt securities at December 31, 2022 were as follows (dollars in thousands).

During the six months ended March 31, 2023, the Company recorded a $ 9,000 net realized loss on 14 held to maturity investment securities all of which had been recognized previously as credit loss.

During the six months ended March 31, 2022, the Company recorded a $ 1,000 net realized gain on 14 held to maturity investment securities all of which had been recognized previously as credit loss.

The recorded amount of investment securities pledged as collateral for public fund deposits, federal treasury tax and loan deposits, FHLB collateral and other non-profit organization deposits totaled $ 215.33 million and $ 133.82 million at March 31, 2023 and September 30, 2022, respectively.

The contractual maturities of debt securities at March 31, 2023 were as follows (dollars in thousands).

Expected maturities may differ from scheduled maturities due to the prepayment of principal or call provisions.

34 unchanged sentences

Any change in these indicators could have a significant negative impact on the Company's financial condition, impact the goodwill impairment analysis or cause the Company to perform a goodwill impairment analysis more frequently than once per year.

As of December 31, 2022, management believes that there have been no events or changes in the circumstances since May 31, 2022 that would indicate a potential impairment of goodwill.

As of March 31, 2023, management believes that there have been no events or changes in the circumstances since May 31, 2022 that would indicate a potential impairment of goodwill.

No assurances can be given, however, that the Company will not record an impairment loss on goodwill in the future.

1 unchanged sentence

Any impairment charge could have a material adverse effect on the Company's results of operations and financial condition.

The recorded amount of goodwill at December 31, 2022 and September 30, 2022 remained unchanged at $ 15.13 million.

The recorded amount of goodwill at March 31, 2023 and September 30, 2022 remained unchanged at $ 15.13 million.

CDI represents the future economic benefit of the potential cost savings from acquiring core deposits as part of a business combination compared to the cost of alternative funding sources.

1 unchanged sentence

CDI is evaluated for impairment whenever events or changes in circumstances indicate that its carrying amount may not be recoverable, with any changes in estimated useful life accounted for prospectively over the revised remaining life.

As of December 31, 2022, management believes that there have been no events or changes in the circumstances that would indicate a potential impairment of CDI.

As of March 31, 2023, management believes that there have been no events or changes in the circumstances that would indicate a potential impairment of CDI.

(4) LOANS RECEIVABLE AND ALLOWANCE FOR LOAN LOSSES

Loans receivable by portfolio segment consisted of the following at December 31, 2022 and September 30, 2022 (dollars in thousands):

Loans receivable by portfolio segment consisted of the following at March 31, 2023 and September 30, 2022 (dollars in thousands):

2023 September 30,

26 unchanged sentences

_____________________________

(1) Does not include one- to four-family loans held for sale totaling $ 0 and $ 748 at December 31, 2022 and September 30, 2022, respectively.

Loans receivable at December 31, 2022 and September 30, 2022 are reported net of unamortized discounts totaling $ 239,000 and $ 267,000 , respectively.

(1) Does not include one- to four-family loans held for sale totaling $ 200 and $ 748 at March 31, 2023 and September 30, 2022, respectively.

Loans receivable at March 31, 2023 and September 30, 2022 are reported net of unamortized discounts totaling $ 225,000 and $ 267,000 , respectively.

Allowance for Loan Losses

The following tables set forth information for the three months ended December 31, 2022 and 2021 regarding activity in the allowance for loan losses by portfolio segment (dollars in thousands):

Three Months Ended December 31, 2022

The following tables set forth information for the three and six months ended March 31, 2023 and 2022 regarding activity in the allowance for loan losses by portfolio segment (dollars in thousands):

Three Months Ended March 31, 2023

Allowance Provision for

16 unchanged sentences

Total $ 14,229 $ 475 $ ( 6 ) $ — $ 14,698

Three Months Ended December 31, 2021

Six Months Ended March 31, 2023

Allowance Provision for

16 unchanged sentences

Total $ 13,703 $ 1,000 $ ( 6 ) $ 1 $ 14,698

The following tables present information on the loans evaluated individually and collectively for impairment in the allowance for loan losses by portfolio segment at December 31, 2022 and September 30, 2022 (dollars in thousands):

Three Months Ended March 31, 2022

Allowance Provision for

(Recapture of) Loan Losses Charge-

offs Recoveries Ending

Mortgage loans:

One- to four-family $ 1,237 $ 10 $ — $ — $ 1,247

Multi-family 748 ( 13 ) — — 735

Commercial 6,807 124 — — 6,931

Construction – custom and owner/builder 671 15 — — 686

Construction – speculative one- to four-family 153 ( 27 ) — — 126

Construction – commercial 593 ( 130 ) — — 463

Construction – multi-family 460 ( 24 ) — — 436

Construction – land development 157 ( 31 ) — — 126

Land 435 ( 58 ) — — 377

Consumer loans:

Home equity and second mortgage 532 ( 63 ) — — 469

Other 48 ( 4 ) ( 1 ) 1 44

Commercial business loans 1,627 201 ( 49 ) 14 1,793

Total $ 13,468 $ — $ ( 50 ) $ 15 $ 13,433

Six Months Ended March 31, 2022

Allowance Provision for

(Recapture of) Loan Losses Charge-

offs Recoveries Ending

Mortgage loans:

One-to four-family $ 1,154 $ 93 $ — $ — $ 1,247

Multi-family 765 ( 30 ) — — 735

Commercial 6,813 118 — — 6,931

Construction – custom and owner/builder 644 42 — — 686

Construction – speculative one- to four-family 188 ( 62 ) — — 126

Construction – commercial 784 ( 321 ) — — 463

Construction – multi-family 436 — — — 436

Construction – land development 124 2 — — 126

Land 470 ( 93 ) — — 377

Consumer loans:

Home equity and second mortgage 528 ( 59 ) — — 469

Other 50 ( 5 ) ( 2 ) 1 44

Commercial business loans 1,513 315 ( 49 ) 14 1,793

Total $ 13,469 $ — $ ( 51 ) $ 15 $ 13,433

The following tables present information on the loans evaluated individually and collectively for impairment in the allowance for loan losses by portfolio segment at March 31, 2023 and September 30, 2022 (dollars in thousands):

Allowance for Loan Losses Recorded Investment in Loans

7 unchanged sentences

Impairment Total

December 31, 2022

March 31, 2023

Mortgage loans:

35 unchanged sentences

Total $ 127 $ 13,576 $ 13,703 $ 4,532 $ 1,145,918 $ 1,150,450

The following tables present an analysis of loans by aging category and portfolio segment at December 31, 2022 and September 30, 2022 (dollars in thousands):

The following tables present an analysis of loans by aging category and portfolio segment at March 31, 2023 and September 30, 2022 (dollars in thousands):

Past Due 60-89

3 unchanged sentences

Past Due Current Total

December 31, 2022

March 31, 2023

Mortgage loans:

51 unchanged sentences

Loans in this classification have the weaknesses of substandard loans with the additional characteristic that the weaknesses make the collection or liquidation in full on the basis of currently existing facts, conditions and values questionable, and there is a high possibility of loss.

At December 31, 2022 and September 30, 2022, there were no loans classified as doubtful.

At March 31, 2023 and September 30, 2022, there were no loans classified as doubtful.

Loans in this classification are considered uncollectible and of such little value that continuance as bankable assets is not warranted.

This classification does not mean that the loan has absolutely no recovery or salvage value, but rather it is not practical or desirable to defer writing off this loan even though partial recovery may be realized in the future.

At December 31, 2022 and September 30, 2022, there were no loans classified as loss.

The following tables present an analysis of loans by credit quality indicator and portfolio segment at December 31, 2022 and September 30, 2022 (dollars in thousands):

December 31, 2022 Pass Watch Special

At March 31, 2023 and September 30, 2022, there were no loans classified as loss.

The following tables present an analysis of loans by credit quality indicator and portfolio segment at March 31, 2023 and September 30, 2022 (dollars in thousands):

March 31, 2023 Pass Watch Special

Mention Substandard Total

43 unchanged sentences

The categories of non-accrual loans and impaired loans overlap, although they are not identical.

The following table is a summary of information related to impaired loans by portfolio segment as of December 31, 2022 and for the three months then ended (dollars in thousands):

The following table is a summary of information related to impaired loans by portfolio segment as of March 31, 2023 and for the three and six months then ended (dollars in thousands):

Investment Unpaid Principal Balance (Loan Balance Plus Charge Off) Related

Allowance Year to Date ("YTD") Average Recorded Investment (1) YTD Interest Income Recognized (1) YTD Cash Basis Interest Income Recognized (1)

Allowance Quarter to Date ("QTD") Average Recorded Investment (1) Year to Date ("YTD") Average Recorded Investment (2) QTD Interest Income Recognized (1) YTD Interest Income Recognized (2) QTD Cash Basis Interest Income Recognized (1) YTD Cash Basis Interest Income Recognized (2)

With no related allowance recorded:

21 unchanged sentences

______________________________________________

(1) For the three months ended December 31, 2022 .

(1) For the three months ended March 31, 2023 .

(2) For the six months ended March 31, 2023.

The following table is a summary of information related to impaired loans by portfolio segment as of and for the year ended September 30, 2022 (dollars in thousands):

38 unchanged sentences

TDRs are classified as non-accrual (and considered to be non-performing) unless they have been performing in accordance with modified terms for a period of at least six months.

The Company had $ 2.58 million and $ 2.62 million in TDRs included in impaired loans at December 31, 2022 and September 30, 2022, respectively, and had no commitments at these dates to lend additional funds on these loans.

There was no allowance for loan losses allocated to TDRs at December 31, 2022 and September 30, 2022.

There were no TDRs for which there was a payment default within the first 12 months of the modification during the three months ended December 31, 2022.

The following tables set forth information with respect to the Company’s TDRs by interest accrual status as of December 31, 2022 and September 30, 2022 (dollars in thousands):

December 31, 2022

The Company had $ 2.60 million and $ 2.62 million in TDRs included in impaired loans at March 31, 2023 and September 30, 2022, respectively, and had no commitments at these dates to lend additional funds on these loans.

There was no allowance for loan losses allocated to TDRs at March 31, 2023 and September 30, 2022.

There were no TDRs for which there was a payment default within the first 12 months of the modification during the six months ended March 31, 2023.

The following tables set forth information with respect to the Company’s TDRs by interest accrual status as of March 31, 2023 and September 30, 2022 (dollars in thousands):

March 31, 2023

Accruing Non-

13 unchanged sentences

Total $ 2,472 $ 143 $ 2,615

There were no new TDRs recognized during the three months ended December 31, 2022.

There were no new TDRs recognized during the six months ended March 31, 2023.

There was one new TDR recognized during the year ended September 30, 2022.

7 unchanged sentences

(1) Modification was a result of an increase in principal balance and a reduction in interest rate and monthly payment.

At December 31, 2022, the Company has operating leases for two retail bank branch offices.

At March 31, 2023, the Company has operating leases for two retail bank branch offices.

The Company's leases have remaining lease terms of four to nine years , both of which include options to extend the leases for up to five years .

Lease extensions are not certain, and the Company evaluates each lease based on the specific circumstances for the location to determine the probability of exercising the extensions in the calculation of ROU assets and liabilities.

The components of lease cost (included in the premises and equipment expense category in the consolidated statements of income) are as follows for the three months ended December 31, 2022 and 2021 (dollars in thousands):

Three Months Ended December 31,

The components of lease cost (included in the premises and equipment expense category in the consolidated statements of income) are as follows for the three and six months ended March 31, 2023 and 2022 (dollars in thousands):

Three Months Ended March 31, Six Months Ended March 31,

2023 2022 2023 2022

Operating lease cost $ 85 $ 94 $ 174 $ 188

1 unchanged sentence

Total lease cost $ 85 $ 94 $ 174 $ 188

The following tables provide supplemental information related to operating leases at or for the three months ended December 31, 2022 and year ended September 30, 2022 (dollars in thousands):

At or For the Three Months Ended December 31 , 2022 At or For the

September 30, 2022

The following tables provide supplemental information related to operating leases at or for the three and six months ended March 31, 2023 and 2022 (dollars in thousands):

At or For the Three Months Ended March 31, 2023 At or For the

Six Months Ended

March 31, 2023

Cash paid for amounts included in the measurement of lease liabilities:

2 unchanged sentences

Weighted average discount rate-operating leases 2.25 % 2.25 %

At or For the Three Months Ended March 31, 2022 At or For the

Six Months Ended

March 31, 2022

Cash paid for amounts included in the measurement of lease liabilities:

Operating cash flows from operating leases $ 87 $ 174

Weighted average remaining lease term-operating leases 8.1 years 8.1 years

Weighted average discount rate-operating leases 2.24 % 2.24 %

The Company's leases typically do not contain a discount rate implicit in the lease contracts.

As an alternative, the weighted average discount rate used to estimate the present value of future lease payments in calculating the value of the ROU asset and liability was determined by utilizing the FHLB fixed-rate credit advance borrowing rate for the term correlating to the remaining term of each lease.

Maturities of operating lease liabilities at December 31, 2022 for future fiscal years are as follows (dollars in thousands):

As an alternative, the weighted average discount rate used to estimate the present value of future lease payments in calculating the value of the ROU asset and lease liability was determined by utilizing the FHLB fixed-rate credit advance borrowing rate for the term correlating to the remaining term of each lease.

Maturities of operating lease liabilities at March 31, 2023 for future fiscal years are as follows (dollars in thousands):

Remainder of 2023 $ 155

7 unchanged sentences

Common stock equivalents arise from the assumed conversion of outstanding stock options to purchase common stock.

Information regarding the calculation of basic and diluted net income per common share for the three months ended December 31, 2022 and 2021 is as follows (dollars in thousands, except per share amounts):

Three Months Ended December 31,

Information regarding the calculation of basic and diluted net income per common share for the three and six months ended March 31, 2023 and 2022 is as follows (dollars in thousands, except per share amounts):

Three Months Ended March 31, Six Months Ended March 31,

2023 2022 2023 2022

Basic net income per common share computation

9 unchanged sentences

____________________________________________

(1) For the three months ended December 31, 2022 and 2021, average options to purchase 182,000 and 210,052 shares of common stock, respectively, were outstanding but not included in the computation of diluted net income per common share, because their effect would have been anti-dilutive.

(1) For the three and six months ended March 31, 2023, average options to purchase 176,867 and 177,484 shares of common stock, respectively, were outstanding but not included in the computation of diluted net income per common share, because their effect would have been anti-dilutive.

For the three and six months ended March 31, 2022, average options to purchase 204,398 and 207,256 shares of common stock, respectively, were outstanding but not included in the computation of diluted net income per common share, because their effect would have been anti-dilutive.

(7) ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

The changes in accumulated other comprehensive income (loss) ("AOCI") by component during the three months ended December 31, 2022 and 2021 are as follows (dollars in thousands):

Three Months Ended December 31, 2022

The changes in accumulated other comprehensive income (loss) ("AOCI") by component during the three and six months ended March 31, 2023 and 2022 are as follows (dollars in thousands):

Three Months Ended March 31, 2023

Changes in fair value of available for sale securities (1) Changes in OTTI on held to maturity securities (1) Total (1)

Balance of AOCI at the beginning of period $ ( 725 ) $ ( 10 ) $ ( 735 )

Other comprehensive income 239 1 240

Balance of AOCI at the end of period $ ( 486 ) $ ( 9 ) $ ( 495 )

Six Months Ended March 31, 2023

Changes in fair value of available for sale securities (1) Changes in OTTI on held to maturity securities (1) Total (1)

Balance of AOCI at the beginning of period $ ( 706 ) $ ( 11 ) $ ( 717 )

Other comprehensive income 220 2 222

Balance of AOCI at the end of period $ ( 486 ) $ ( 9 ) $ ( 495 )

Three Months Ended March 31, 2022

Changes in fair value of available for sale securities (1) Changes in OTTI on held to maturity securities (1) Total (1)

Balance of AOCI at the beginning of period $ 57 $ ( 15 ) $ 42

Other comprehensive income (loss) ( 152 ) 3 ( 149 )

Balance of AOCI at the end of period $ ( 95 ) $ ( 12 ) $ ( 107 )

Three Months Ended December 31, 2021

Six Months Ended March 31, 2022

Changes in fair value of available for sale securities (1) Changes in OTTI on held to maturity securities (1) Total (1)

6 unchanged sentences

Under the Company’s 2003 Stock Option Plan, the Company was able to grant options for up to 300,000 shares of common stock to employees, officers, directors and directors emeriti.

Under the Company's 2014 Equity Incentive Plan, the Company is able to grant options and awards of restricted stock (with or without performance measures) for up to 352,366 shares of common stock to employees, officers, directors and directors emeriti.

Under the Company's 2014 Equity Incentive Plan, the Company is able to grant options and awards of restricted stock (with or without performance measures) for up to 352,366 shares of

common stock to employees, officers, directors and directors emeriti.

Under the Company's 2019 Equity Incentive Plan, the Company is able to grant options and awards or restricted stock (with or without performance measures) for up to 350,000 shares of common stock, of which 300,000 shares are reserved to be awarded to employees, including officers, and 50,000 shares are reserved to be awarded to directors and directors emeriti.

2 unchanged sentences

Generally, options and restricted stock vest in 20 % annual installments on each of the five anniversaries from the date of the grant, and options generally have a maximum contractual term of ten years from the date of grant.

At December 31, 2022, there were 2,196 shares of common stock available which may be awarded as options or restricted stock pursuant to future grant under the 2014 Equity Incentive Plan.

At December 31 2022, there were 196,700 shares of common stock available which may be awarded as options or restricted stock pursuant to future grant under the 2019 Equity Incentive Plan.

At both December 31, 2022 and 2021, there were no unvested restricted stock awards.

There were no restricted stock grants awarded during the three months ended December 31, 2022 and 2021.

Stock option activity for the three months ended December 31, 2022 and 2021 is summarized as follows:

Three Months Ended December 31, 2022 Three Months Ended December 31, 2021

At March 31, 2023, there were 1,796 shares of common stock available which may be awarded as options or restricted stock pursuant to future grant under the 2014 Equity Incentive Plan.

At March 31, 2023, there were 198,900 shares of common stock available which may be awarded as options or restricted stock pursuant to future grant under the 2019 Equity Incentive Plan.

At both March 31, 2023 and 2022, there were no unvested restricted stock awards.

There were no restricted stock grants awarded during the six months ended March 31, 2023 and 2022.

Stock option activity for the six months ended March 31, 2023 and 2022 is summarized as follows:

Six Months Ended March 31, 2023 Six Months Ended March 31, 2022

Number of Shares Weighted

6 unchanged sentences

The fair value of stock options is determined using the Black-Scholes valuation model.

There were no options granted during the three months ended December 31, 2022.

The aggregate intrinsic value of options exercised during the three months ended December 31, 2022 and 2021 was $ 244,000 and $ 123,000 , respectively.

At December 31, 2022, there were 191,710 unvested options with an aggregate grant date fair value of $ 1.08 million, all of which the Company assumes will vest.

The aggregate intrinsic value of unvested options at December 31, 2022 was $ 1.61 million.

There were 200 options vested during the three months ended December 31, 2022 with a total fair value of $ 652 .

At December 31, 2021, there were 176,670 unvested options with an aggregate grant date fair value of $ 844,000 .

There were 200 options that vested during the three months ended December 31, 2021 with a total fair value of $ 1,000 .

Additional information regarding options outstanding at December 31, 2022 is as follows:

The weighted average assumptions for options granted during the six months ended March 31, 2023 were as follows:

Expected volatility 33 %

Expected life (in years) 5

Expected dividend yield 2.99 %

Risk free interest rate 3.58 %

Grant date fair value per share $ 8.65

The aggregate intrinsic value of options exercised during the six months ended March 31, 2023 and 2022 was $ 337,000 and $ 443,000 , respectively.

At March 31, 2023, there were 189,910 unvested options with an aggregate grant date fair value of $ 1.07 million, all of which the Company assumes will vest.

The aggregate intrinsic value of unvested options at March 31, 2023 was $ 371,000 .

There were 200 options vested during the six months ended March 31, 2023 with a total fair value of $ 1,000 .

At March 31, 2022, there were 178,670 unvested options with an aggregate grant date fair value of $ 847,000 .

There were 400 options that vested during the six months ended March 31, 2022 with a total fair value of $ 2,000 .

Additional information regarding options outstanding at March 31, 2023 is as follows:

Options Outstanding Options Exercisable

10 unchanged sentences

392,270 $ 23.50 6.3 202,360 $ 21.35 4.4

The aggregate intrinsic value of options outstanding at December 31, 2022 and 2021 was $ 4.28 million and $ 2.62 million , respectively.

As of December 31, 2022, unrecognized compensation cost related to unvested stock options was $ 1.04 million, which is expected to be recognized over a weighted average life of 2.42 years.

The aggregate intrinsic value of options outstanding at March 31, 2023 and 2022 was $ 1.78 million and $ 2.17 million , respectively.

As of March 31, 2023, unrecognized compensation cost related to unvested stock options was $ 972,000 , which is expected to be recognized over a weighted average life of 5.00 years.

(9) FAIR VALUE MEASUREMENTS

10 unchanged sentences

The estimated fair values of mutual funds are based upon quoted market prices (Level 1).

The Company had no liabilities measured at fair value on a recurring basis at December 31, 2022 and September 30, 2022.

The Company's assets measured at estimated fair value on a recurring basis at December 31, 2022 and September 30, 2022 were as follows (dollars in thousands):

December 31, 2022 Estimated Fair Value

The Company had no liabilities measured at fair value on a recurring basis at March 31, 2023 and September 30, 2022.

The Company's assets measured at estimated fair value on a recurring basis at March 31, 2023 and September 30, 2022 were as follows (dollars in thousands):

March 31, 2023 Estimated Fair Value

Level 1 Level 2 Level 3 Total

11 unchanged sentences

Total $ 835 $ 41,415 $ — $ 42,250

There were no transfers among Level 1, Level 2 and Level 3 during the three months ended December 31, 2022 and the year ended September 30, 2022.

There were no transfers among Level 1, Level 2 and Level 3 during the six months ended March 31, 2023 and the year ended September 30, 2022.

The Company may be required, from time to time, to measure certain assets and liabilities at fair value on a non-recurring basis in accordance with GAAP.

7 unchanged sentences

Impaired loans are evaluated on a quarterly basis for additional impairment and adjusted accordingly.

The following table summarizes the balances of assets measured at estimated fair value on a non-recurring basis at December 31, 2022 (dollars in thousands):

The following table summarizes the balances of assets measured at estimated fair value on a non-recurring basis at March 31, 2023 (dollars in thousands):

Estimated Fair Value

3 unchanged sentences

Total $ — $ — $ 126

The following table presents quantitative information about Level 3 fair value measurements for financial instruments measured at fair value on a non-recurring basis as of December 31, 2022 (dollars in thousands):

The following table presents quantitative information about Level 3 fair value measurements for financial instruments measured at fair value on a non-recurring basis as of March 31, 2023 (dollars in thousands):

Fair Value Valuation

16 unchanged sentences

The disclosures also do not include estimated fair value amounts for certain items which are not defined as financial instruments but for which may have significant value.

The Company does not believe that it would be practicable to estimate a representative fair value for these types of items as of December 31, 2022 and September 30, 2022.

The Company does not believe that it would be practicable to estimate a representative fair value for these types of items as of March 31, 2023 and September 30, 2022.

Because GAAP excludes certain items from fair value disclosure requirements, any aggregation of the fair value amounts presented would not represent the underlying value of the Company.

Additionally, in accordance with GAAP, the Company uses the exit price notion in calculating the fair values of financial instruments not measured at fair value on a recurring basis.

The recorded amounts and estimated fair values of financial instruments were as follows as of December 31, 2022 and September 30, 2022 (dollars in thousands):

December 31, 2022

The recorded amounts and estimated fair values of financial instruments were as follows as of March 31, 2023 and September 30, 2022 (dollars in thousands):

March 31, 2023

Fair Value Measurements Using:

7 unchanged sentences

Other investments 3,000 3,000 3,000 — —

Loans held for sale 200 204 204 — —

Loans receivable, net 1,210,193 1,171,041 — — 1,171,041

25 unchanged sentences

ASU 2016-13 also changes the accounting for PCI debt securities and loans.

ASU 2016-13 retains many of the current disclosure requirements in GAAP and expands certain disclosure requirements.

"smaller reporting company" filer with the U.S.

2016-13 retains many of the current disclosure requirements in GAAP and expands certain disclosure requirements.

As a "smaller reporting company" filer with the U.S.

Securities and Exchange Commission, ASU 2016-13 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years.

14 unchanged sentences

ASU 2017-04 is effective for annual or interim goodwill impairment tests in fiscal years beginning after December 15, 2022.

The adoption ASU 2017-04 is not expected to have a material impact on the Company's future consolidated financial statements.

The adoption of ASU 2017-04 is not expected to have a material impact on the Company's future consolidated financial statements.

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848):

3 unchanged sentences

This ASU is effective for all entities as of March 12, 2020 through December 31, 2024.

The Company has not adopted ASU 2020-04 as of December 31, 2022.

The Company has not adopted ASU 2020-04 as of March 31, 2023.

The adoption of ASU 2020-04 is not expected to have a material impact on the Company's future consolidated financial statements.

8 unchanged sentences

Revenue reported as service charges on deposits, ATM and debit card interchange transaction fees, merchant services fees, non-deposit investment fees and escrow fees are within the scope of ASC 606.

All of the Company's revenue from contracts with customers within the scope of ASC 60 6 is recognized in non-interest income with the exception of gains on sales of OREO and gains on sales/disposition of premises and equipment, which are included in non-interest expense.

For the three months ended December 31, 2022, the Company recognized $ 947,000 in service charges on deposits, $ 1.25 million in ATM and debit card interchange transaction fees, $ 30,000 in escrow fees, and $ 30,000 in fee income from non-deposit investment sales, all considered within the scope of ASC 606.

For the three months ended December 31, 2021, the Company recognized $ 913,000 in service charges on deposits, $ 1.28 million in ATM and debit card interchange transaction fees, $ 78,000 in escrow fees, and $ 2,000 in fee income from non-deposit investment sales, all considered within the scope of ASC 606.

All of the Company's revenue from contracts with customers withi n the scope of ASC 606 is recognized in non-interest income with the exception of gains on sales of OREO and gains on sales/disposition of premises and equipment, which are included in non-interest expense.

For the three months ended March 31, 2023, the Company recognized $ 893,000 in service charges on deposits, $ 1.28 million in ATM and debit card interchange transaction fees, $ 29,000 in escrow fees, and $ 4,000 in fee income from non-deposit investment sales.

For the six months ended March 31, 2023, the Company recognized $ 1.84 million in service charges on deposits, $ 2.53 million in ATM and debit card interchange transaction fees, $ 59,000 in escrow fees and $ 34,000 in fee income from non-deposit investment sales.

For the three months ended March 31, 2022, the Company recognized

$ 1.01 million in service charges on deposits, $ 1.25 million in ATM and debit card interchange transaction fees, $ 44,000 in escrow fees, and $ 8,000 in fee income from non-deposit investment sales.

For the six months ended March 31, 2022, the Company recognized $ 1.93 million in service charges on deposits, $ 2.52 million in ATM and debit card interchanges transaction fees, $ 123,000 in escrow fees, and $ 10,000 in fee income from non-deposit investment sales.

If a contract is determined to be within the scope of ASC 606, the Company recognizes revenue when it satisfies its performance obligation.

27 unchanged sentences

Collateral held varies, but may include accounts receivable, inventory, property and equipment, residential real estate, land and income-producing commercial properties.

A summary of the Company's commitments at December 31, 2022 and 2021 are listed below (in thousands):

December 31, 2022 December 31, 2021

A summary of the Company's commitments at March 31, 2023 and 2022 are listed below (in thousands):

March 31, 2023 March 31, 2022

Undisbursed portion of construction loans in process (see Note 4) $ 99,253 $ 100,719

3 unchanged sentences

The Company maintains a separate reserve for losses related to unfunded loan commitments.

Management estimates the amount of probable losses related to unfunded loan commitments by applying the loss factors used in the allowance for loan loss methodology to an estimate of the expected amount of funding and applies this adjusted factor to the unused portion of unfunded loan commitments.

The reserve for unfunded loan commitments totaled $ 320,000 and $ 362,000 at December 31, 2022 and 2021, respectively.

unfunded loan commitments.

The reserve for unfunded loan commitments totaled $ 320,000 and $ 345,000 at March 31, 2023 and 2022, respectively.

These amounts are included in other liabilities and accrued expenses in the accompanying consolidated balance sheets.

Increases (decreases) in the reserve for unfunded loan commitments are recorded in non-interest expense in the accompanying consolidated statements of income.

The Bank has an employee severance compensation plan which expires in 2027 and which provides severance pay benefits to eligible employees in the event of a change in control of Timberland Bancorp or the Bank (as defined in the plan).

The Bank has an employee severance compensation plan which expires in 2027 and provides for severance pay benefits to eligible employees in the event of a change in control of Timberland Bancorp or the Bank (as defined in the plan).

In general, all employees with two or more years of service will be eligible to participate in the plan.

5 unchanged sentences

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 1. Financial Statements